OSTEONIC Past Earnings Performance
Past criteria checks 2/6
OSTEONIC has been growing earnings at an average annual rate of 98.2%, while the Medical Equipment industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 28.3% per year. OSTEONIC's return on equity is 10.9%, and it has net margins of 19%.
Key information
98.2%
Earnings growth rate
93.5%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 28.3% |
| Return on equity | 10.9% |
| Net Margin | 19.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings
Nov 19
There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings
Mar 31Recent updates
Do OSTEONIC's (KOSDAQ:226400) Earnings Warrant Your Attention?
Dec 07There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings
Nov 19Does OSTEONIC (KOSDAQ:226400) Have A Healthy Balance Sheet?
Nov 15OSTEONIC (KOSDAQ:226400) Is Experiencing Growth In Returns On Capital
Aug 09There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings
Mar 31OSTEONIC (KOSDAQ:226400) Seems To Use Debt Rather Sparingly
Feb 27Is Osteonic (KOSDAQ:226400) A Risky Investment?
Mar 25Revenue & Expenses Breakdown
How OSTEONIC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 32,543 | 6,181 | 6,261 | 1,915 |
| 30 Jun 24 | 31,125 | 5,882 | 6,226 | 1,769 |
| 31 Mar 24 | 29,247 | 4,445 | 5,968 | 1,537 |
| 31 Dec 23 | 27,799 | 3,658 | 6,262 | 1,254 |
| 30 Sep 23 | 25,973 | 470 | 5,766 | 586 |
| 30 Jun 23 | 24,342 | -452 | 5,740 | 458 |
| 31 Mar 23 | 22,131 | -171 | 5,455 | 484 |
| 31 Dec 22 | 19,839 | 836 | 4,926 | 454 |
| 30 Sep 22 | 18,116 | 2,345 | 5,760 | 297 |
| 30 Jun 22 | 17,269 | 2,264 | 5,492 | 302 |
| 31 Mar 22 | 16,338 | -70 | 5,629 | 267 |
| 31 Dec 21 | 15,598 | -2,852 | 5,062 | 256 |
Quality Earnings: A226400 has a high level of non-cash earnings.
Growing Profit Margin: A226400's current net profit margins (19%) are higher than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A226400's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare A226400's past year earnings growth to its 5-year average.
Earnings vs Industry: A226400 earnings growth over the past year (1214.4%) exceeded the Medical Equipment industry -13.3%.
Return on Equity
High ROE: A226400's Return on Equity (10.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 18:13 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
OSTEONIC Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yeon Sung Jung | NH Investment & Securities Co., Ltd. |
| Byung Hwa Lee | Shinhan Investment Corp. |